SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-032947
Filing Date
2013-06-05
Accepted
2013-06-05 16:58:58
Documents
1
Period of Report
2013-06-03

Document Format Files

Seq Description Document Type Size
1 rrd382250.html 4  
1 rrd382250.xml 4 4247
  Complete submission text file 0001181431-13-032947.txt   5742
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting) CIK: 0001452907 (see all company filings)

State of Incorp.: E9
Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 13894861

Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations